查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1420930

免疫分析市場 - 2023-2031 年全球產業分析、規模、佔有率、成長、趨勢與預測

Immunoassay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 336 Pages | 商品交期: 2-10個工作天內

價格

免疫分析市場 - 報告範圍

TMR 關於全球免疫分析市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了該期間全球免疫分析市場的收入2017-2031年，以2023年為基準年，2031年為預測年。報告中也提供了2023年至2031年全球免疫分析市場的年複合成長率（CAGR %）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解免疫分析市場。

市場概況
2023年市場價值 315 億美元
2031 年市場價值 487 億美元
CAGR 5%

該報告深入探討了全球免疫分析市場的競爭格局。全球免疫分析市場的主要參與者已被確定，並且每一位參與者都已根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球免疫分析市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2017-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 管道分析
  • 主要產品/品牌分析
  • 主要併購
  • COVID-19 大流行對該行業的影響

第 6 章：全球市場分析與預測：依產品分類

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：按產品，2017-2031
    • 分析儀
    • 耗材
  • 市場吸引力：依產品分類

第 7 章：全球市場分析與預測：依技術分類

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：依技術分類，2017-2031
    • 化學發光（CLIA）
    • 酶聯 (ELISA)
    • 酵素連結免疫螢光分析 (ELFA)
    • 廣播電台（RIA）
    • 其他
    • 7.4 市場吸引力：依技術分類

第 8 章：全球市場分析與預測：按應用分類

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：依應用分類，2017-2031
    • 傳染病
    • 內分泌科
    • 腫瘤學
    • 心臟病學
    • 骨科
    • 其他
  • 市場吸引力：按應用分類

第 9 章：全球市場分析與預測：按最終用戶

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2017-2031
    • 醫院和診斷實驗室
    • 血庫
    • 其他
  • 市場吸引力：按最終用戶分類

第 10 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2017-2031
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力：按地區

第 11 章：北美市場分析與預測

第 12 章：歐洲市場分析與預測

第 13 章：亞太市場分析與預測

第 14 章：拉丁美洲市場分析與預測

第 15 章：中東和非洲市場分析與預測

第16章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2022 年）
  • 公司簡介
    • F. Hoffmann-La Roche Ltd.
    • Danaher Corporation
    • Abbott Laboratories
    • Siemens Healthineers (Siemens AG)
    • DiaSorin SpA
    • Sysmex Corporation
    • bioMerieux SA
    • Ortho Clinical Diagnostics
    • Thermo Fisher Scientific, Inc.
    • Becton, Dickinson and Company
    • Merck kGaA
Product Code: TMRGL19703

Immunoassay Market - Scope of Report

TMR's report on the global immunoassay market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global immunoassay market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global immunoassay market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the immunoassay market.

Market Snapshot
Market Value in 2023US$ 31.5 Bn
Market Value in 2031US$ 48.7 Bn
CAGR5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global immunoassay market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global immunoassay market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global immunoassay market.

The report delves into the competitive landscape of the global immunoassay market. Key players operating in the global immunoassay market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global immunoassay market profiled in this report.

Key Questions Answered in Global immunoassay Market Report:

  • What is the sales/revenue generated by immunoassay across all regions during the forecast period?
  • What are the opportunities in the global immunoassay market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Immunoassay Market - Research Objectives and Research Approach

The comprehensive report on the global immunoassay market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global immunoassay market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global immunoassay market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Immunoassay Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Immunoassay Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Immunoassay Market Analysis and Forecast, by Product

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Analyzers
    • 6.3.2. Consumables
  • 6.4. Market Attractiveness, by Product

7. Global Immunoassay Market Analysis and Forecast, by Technology

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Technology, 2017-2031
    • 7.3.1. Chemiluminescence Immunoassay (CLIA)
    • 7.3.2. Enzyme-linked Immunoassay (ELISA)
    • 7.3.3. Enzyme-linked Immunofluorescent Assay (ELFA)
    • 7.3.4. Radioimmunoassay (RIA)
    • 7.3.5. Others
    • 7.3.6. 7.4 Market Attractiveness, by Technology

8. Global Immunoassay Market Analysis and Forecast, by Application

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application, 2017-2031
    • 8.3.1. Infectious Disease
    • 8.3.2. Endocrinology
    • 8.3.3. Oncology
    • 8.3.4. Cardiology
    • 8.3.5. Orthopedics
    • 8.3.6. Others
  • 8.4. Market Attractiveness, by Application

9. Global Immunoassay Market Analysis and Forecast, by End-user

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals & Diagnostic Laboratories
    • 9.3.2. Blood Banks
    • 9.3.3. Others
  • 9.4. Market Attractiveness, by End-user

10. Global Immunoassay Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America Immunoassay Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017-2031
    • 11.2.1. Analyzers
    • 11.2.2. Consumables
  • 11.3. Market Attractiveness, by Product
  • 11.4. Market Value Forecast, by Technology, 2017-2031
    • 11.4.1. Chemiluminescence Immunoassay (CLIA)
    • 11.4.2. Enzyme-linked Immunoassay (ELISA)
    • 11.4.3. Enzyme-linked Immunofluorescent Assay (ELFA)
    • 11.4.4. Radioimmunoassay (RIA)
    • 11.4.5. Others
  • 11.5. Market Attractiveness, by Technology
  • 11.6. Market Value Forecast, by Application, 2017-2031
    • 11.6.1. Infectious Disease
    • 11.6.2. Endocrinology
    • 11.6.3. Oncology
    • 11.6.4. Cardiology
    • 11.6.5. Orthopedics
    • 11.6.6. Others
  • 11.7. Market Attractiveness, by Application
  • 11.8. Market Value Forecast, by End-user, 2017-2031
    • 11.8.1. Hospitals & Diagnostic Laboratories
    • 11.8.2. Blood Banks
    • 11.8.3. Others
  • 11.9. Market Attractiveness, by End-user
  • 11.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Product
    • 11.11.2. By Technology
    • 11.11.3. By Application
    • 11.11.4. By End-user
    • 11.11.5. By Country

12. Europe Immunoassay Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Analyzers
    • 12.2.2. Consumables
  • 12.3. Market Attractiveness, by Product
  • 12.4. Market Value Forecast, by Technology, 2017-2031
    • 12.4.1. Chemiluminescence Immunoassay (CLIA)
    • 12.4.2. Enzyme-linked Immunoassay (ELISA)
    • 12.4.3. Enzyme-linked Immunofluorescent Assay (ELFA)
    • 12.4.4. Radioimmunoassay (RIA)
    • 12.4.5. Others
  • 12.5. Market Attractiveness, by Technology
  • 12.6. Market Value Forecast, by Application, 2017-2031
    • 12.6.1. Infectious Disease
    • 12.6.2. Endocrinology
    • 12.6.3. Oncology
    • 12.6.4. Cardiology
    • 12.6.5. Orthopedics
    • 12.6.6. Others
  • 12.7. Market Attractiveness, by Application
  • 12.8. Market Value Forecast, by End-user, 2017-2031
    • 12.8.1. Hospitals & Diagnostic Laboratories
    • 12.8.2. Blood Banks
    • 12.8.3. Others
  • 12.9. Market Attractiveness, by End-user
  • 12.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Product
    • 12.11.2. By Technology
    • 12.11.3. By Application
    • 12.11.4. By End-user
    • 12.11.5. By Country/Sub-region

13. Asia Pacific Immunoassay Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. Analyzers
    • 13.2.2. Consumables
  • 13.3. Market Attractiveness, by Product
  • 13.4. Market Value Forecast, by Technology, 2017-2031
    • 13.4.1. Chemiluminescence Immunoassay (CLIA)
    • 13.4.2. Enzyme-linked Immunoassay (ELISA)
    • 13.4.3. Enzyme-linked Immunofluorescent Assay (ELFA)
    • 13.4.4. Radioimmunoassay (RIA)
    • 13.4.5. Others
  • 13.5. Market Attractiveness, by Technology
  • 13.6. Market Value Forecast, by Application, 2017-2031
    • 13.6.1. Infectious Disease
    • 13.6.2. Endocrinology
    • 13.6.3. Oncology
    • 13.6.4. Cardiology
    • 13.6.5. Orthopedics
    • 13.6.6. Others
  • 13.7. Market Attractiveness, by Application
  • 13.8. Market Value Forecast, by End-user, 2017-2031
    • 13.8.1. Hospitals & Diagnostic Laboratories
    • 13.8.2. Blood Banks
    • 13.8.3. Others
  • 13.9. Market Attractiveness, by End-user
  • 13.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Product
    • 13.11.2. By Technology
    • 13.11.3. By Application
    • 13.11.4. By End-user
    • 13.11.5. By Country/Sub-region

14. Latin America Immunoassay Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2017-2031
    • 14.2.1. Analyzers
    • 14.2.2. Consumables
  • 14.3. Market Attractiveness, by Product
  • 14.4. Market Value Forecast, by Technology, 2017-2031
    • 14.4.1. Chemiluminescence Immunoassay (CLIA)
    • 14.4.2. Enzyme-linked Immunoassay (ELISA)
    • 14.4.3. Enzyme-linked Immunofluorescent Assay (ELFA)
    • 14.4.4. Radioimmunoassay (RIA)
    • 14.4.5. Others
  • 14.5. Market Attractiveness, by Technology
  • 14.6. Market Value Forecast, by Application, 2017-2031
    • 14.6.1. Infectious Disease
    • 14.6.2. Endocrinology
    • 14.6.3. Oncology
    • 14.6.4. Cardiology
    • 14.6.5. Orthopedics
    • 14.6.6. Others
  • 14.7. Market Attractiveness, by Application
  • 14.8. Market Value Forecast, by End-user, 2017-2031
    • 14.8.1. Hospitals & Diagnostic Laboratories
    • 14.8.2. Blood Banks
    • 14.8.3. Others
  • 14.9. Market Attractiveness, by End-user
  • 14.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Product
    • 14.11.2. By Technology
    • 14.11.3. By Application
    • 14.11.4. By End-user
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa Immunoassay Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product, 2017-2031
    • 15.2.1. Analyzers
    • 15.2.2. Consumables
  • 15.3. Market Attractiveness, by Product
  • 15.4. Market Value Forecast, by Technology, 2017-2031
    • 15.4.1. Chemiluminescence Immunoassay (CLIA)
    • 15.4.2. Enzyme-linked Immunoassay (ELISA)
    • 15.4.3. Enzyme-linked Immunofluorescent Assay (ELFA)
    • 15.4.4. Radioimmunoassay (RIA)
    • 15.4.5. Others
  • 15.5. Market Attractiveness, by Technology
  • 15.6. Market Value Forecast, by Application, 2017-2031
    • 15.6.1. Infectious Disease
    • 15.6.2. Endocrinology
    • 15.6.3. Oncology
    • 15.6.4. Cardiology
    • 15.6.5. Orthopedics
    • 15.6.6. Others
  • 15.7. Market Attractiveness, by Application
  • 15.8. Market Value Forecast, by End-user, 2017-2031
    • 15.8.1. Hospitals & Diagnostic Laboratories
    • 15.8.2. Blood Banks
    • 15.8.3. Others
  • 15.9. Market Attractiveness, by End-user
  • 15.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Product
    • 15.11.2. By Technology
    • 15.11.3. By Application
    • 15.11.4. By End-user
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. F. Hoffmann-La Roche Ltd.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Danaher Corporation
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Abbott Laboratories
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Siemens Healthineers (Siemens AG)
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. DiaSorin S.p.A.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Sysmex Corporation
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. bioMerieux SA
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Ortho Clinical Diagnostics
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Thermo Fisher Scientific, Inc.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Becton, Dickinson and Company
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. Merck kGaA
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview

List of Tables

  • Table 01: Global Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 03: Global Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 05: Global Immunoassay Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Immunoassay Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 08: North America Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 09: North America Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 10: North America Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe Immunoassay Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 13: Europe Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 14: Europe Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 15: Europe Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 18: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 19: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 20: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 23: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 24: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 25: Latin America Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 26: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 28: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 29: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 30: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Immunoassay Market Size (US$ Mn), by Region, 2022 and 2031
  • Figure 02: Global Immunoassay Market Revenue (US$ Mn), by Product, 2022
  • Figure 03: Global Immunoassay Market Value Share, by Product, 2022
  • Figure 04: Global Immunoassay Market Revenue (US$ Mn), by Technology, 2022
  • Figure 05: Global Immunoassay Market Value Share, by Technology, 2022
  • Figure 06: Global Immunoassay Market Revenue (US$ Mn), by Application, 2022
  • Figure 07: Global Immunoassay Market Value Share, by Application, 2022
  • Figure 08: Global Immunoassay Market Revenue (US$ Mn), by End-user, 2022
  • Figure 09: Global Immunoassay Market Value Share, by End-user, 2022
  • Figure 10: Global Immunoassay Market Value Share, by Region, 2022
  • Figure 11: Global Immunoassay Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 12: Global Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 13: Global Immunoassay Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 14: Global Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 15: Global Immunoassay Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 16: Global Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 17: Global Immunoassay Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 18: Global Immunoassay Market Revenue (US$ Mn), by End-user, 2022
  • Figure 19: Global Immunoassay Market Value Share, by End-user, 2022
  • Figure 20: Global Immunoassay Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 21: Global Immunoassay Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 22: North America Immunoassay Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 23: North America Immunoassay Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 24: North America Immunoassay Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 25: North America Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 26: North America Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 27: North America Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 28: North America Immunoassay Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 29: North America Immunoassay Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 30: North America Immunoassay Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 31: North America Immunoassay Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 32: North America Immunoassay Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 33: Europe Immunoassay Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 34: Europe Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 35: Europe Immunoassay Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 36: Europe Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 37: Europe Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 38: Europe Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 39: Europe Immunoassay Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 40: Europe Immunoassay Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 41: Europe Immunoassay Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 42: Europe Immunoassay Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 43: Europe Immunoassay Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 44: Asia Pacific Immunoassay Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 45: Asia Pacific Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 46: Asia Pacific Immunoassay Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 47: Asia Pacific Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 48: Asia Pacific Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 49: Asia Pacific Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 50: Asia Pacific Immunoassay Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 51: Asia Pacific Immunoassay Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 52: Asia Pacific Immunoassay Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 53: Asia Pacific Immunoassay Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 54: Asia Pacific Immunoassay Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 55: Latin America Immunoassay Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 56: Latin America Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 57: Latin America Immunoassay Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 58: Latin America Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 59: Latin America Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 60: Latin America Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 61: Latin America Immunoassay Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 62: Latin America Immunoassay Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 63: Latin America Immunoassay Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 64: Latin America Immunoassay Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 65: Latin America Immunoassay Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 66: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 67: Middle East & Africa Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 68: Middle East & Africa Immunoassay Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 69: Middle East & Africa Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 70: Middle East & Africa Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 71: Middle East & Africa Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 72: Middle East & Africa Immunoassay Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 73: Middle East & Africa Immunoassay Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 74: Middle East & Africa Immunoassay Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 75: Middle East & Africa Immunoassay Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 76: Middle East & Africa Immunoassay Market Attractiveness Analysis, by End-user, 2023-2031